Who
Guy Levy
10% owner
Company insider
Files Form 4 as: 10% owner, Parabilis Medicines; Director, BioAtla.
In numbers
- Trades disclosed
- 15
- Buys
- 2
- Sells
- 2
- Bought
- $35.0M
- Sold
- $37.3M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 18 Dec 2020
- Last trade
- 11 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 29 Jun 2026 | PBLS Parabilis MedicinesBiotechnology | SEC FORM 4 Bought | $7.5M375,000 at $20.00 | filing |
| 11 Jun 2026filed 29 Jun 2026 | PBLS Parabilis MedicinesBiotechnology | SEC FORM 4 Bought | $2.5M125,000 at $20.00 | filing |
| 11 Jun 2026filed 29 Jun 2026 | PBLS Parabilis MedicinesBiotechnology | SEC FORM 4 Code C | $5.0M527,070 at $9.48 | filing |
| 11 Jun 2026filed 29 Jun 2026 | PBLS Parabilis Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code C | —527,070 at $0.00 | filing |
| 30 Sep 2021filed 30 Sep 2021 | BioAtlaBiotechnology | SEC FORM 4 Code A | $7.5M267,900 at $28.00 | filing |
| 24 Aug 2021filed 26 Aug 2021 | BioAtlaBiotechnology | SEC FORM 4 Sold | $11.3M285,874 at $39.65 | filing |
| 24 Aug 2021filed 26 Aug 2021 | BioAtlaBiotechnology | SEC FORM 4 Sold | $2.1M53,195 at $39.65 | filing |
| 24 Aug 2021filed 26 Aug 2021 | BioAtlaBiotechnology | SEC FORM 4 Sold | $8.2M207,640 at $39.65 | filing |
| 17 Jun 2021filed 21 Jun 2021 | BioAtlaBiotechnology | SEC FORM 4 Sold | $13.2M337,220 at $39.16 | filing |
| 17 Jun 2021filed 21 Jun 2021 | BioAtlaBiotechnology | SEC FORM 4 Sold | $2.5M62,780 at $39.16 | filing |
| 15 Jun 2021filed 16 Jun 2021 | BioAtlaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,307 at $0.00 | filing |
| 18 Dec 2020filed 22 Dec 2020 | BioAtlaoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,790,472 at $0.00 | filing |
| 18 Dec 2020filed 22 Dec 2020 | BioAtlaBiotechnology | SEC FORM 4 Code C | —1,790,472 at $0.00 | filing |
| 18 Dec 2020filed 22 Dec 2020 | BioAtlaBiotechnology | SEC FORM 4 Bought | $19.0M1,055,557 at $18.00 | filing |
| 18 Dec 2020filed 22 Dec 2020 | BioAtlaBiotechnology | SEC FORM 4 Bought | $6.0M333,333 at $18.00 | filing |
News
Parabilis Medicines (NASDAQ:PBLS) Shares Up 4.9% – Here's What HappenedPBLS · themarketsdaily.com · 19 Oct 2026Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous PolyposisPBLS · manilatimes.net · 14 Oct 2026
0 headlines in the last 90 days name Guy Levy; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.